JP2016531105A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531105A5 JP2016531105A5 JP2016527071A JP2016527071A JP2016531105A5 JP 2016531105 A5 JP2016531105 A5 JP 2016531105A5 JP 2016527071 A JP2016527071 A JP 2016527071A JP 2016527071 A JP2016527071 A JP 2016527071A JP 2016531105 A5 JP2016531105 A5 JP 2016531105A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- disease
- syndrome
- pharmaceutical composition
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361847455P | 2013-07-17 | 2013-07-17 | |
| US61/847,455 | 2013-07-17 | ||
| PCT/US2014/046839 WO2015009820A2 (en) | 2013-07-17 | 2014-07-16 | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019019259A Division JP2019112406A (ja) | 2013-07-17 | 2019-02-06 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531105A JP2016531105A (ja) | 2016-10-06 |
| JP2016531105A5 true JP2016531105A5 (enExample) | 2017-08-24 |
| JP6479789B2 JP6479789B2 (ja) | 2019-03-13 |
Family
ID=52346836
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016527071A Expired - Fee Related JP6479789B2 (ja) | 2013-07-17 | 2014-07-16 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2019019259A Pending JP2019112406A (ja) | 2013-07-17 | 2019-02-06 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2021031378A Pending JP2021090447A (ja) | 2013-07-17 | 2021-03-01 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019019259A Pending JP2019112406A (ja) | 2013-07-17 | 2019-02-06 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
| JP2021031378A Pending JP2021090447A (ja) | 2013-07-17 | 2021-03-01 | 組織の損傷に関連した疾患及び障害を予防及び治療する、組織保護ペプチド及びペプチド類似体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20160168199A1 (enExample) |
| EP (1) | EP3021863A4 (enExample) |
| JP (3) | JP6479789B2 (enExample) |
| KR (1) | KR20160052537A (enExample) |
| CN (1) | CN105517561A (enExample) |
| AU (2) | AU2014290116A1 (enExample) |
| CA (1) | CA2918223A1 (enExample) |
| HK (1) | HK1223298A1 (enExample) |
| IL (1) | IL243551A0 (enExample) |
| MX (1) | MX2016000448A (enExample) |
| SG (2) | SG10201809099PA (enExample) |
| WO (1) | WO2015009820A2 (enExample) |
| ZA (1) | ZA201600362B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8962015B2 (en) | 2007-09-28 | 2015-02-24 | Sdg, Inc. | Orally bioavailable lipid-based constructs |
| CN109310741A (zh) * | 2016-04-29 | 2019-02-05 | 阿拉伊姆药品公司 | 用于预防和治疗与组织损伤相关的疾病和障碍的组织保护肽 |
| KR102167641B1 (ko) * | 2018-08-27 | 2020-10-19 | 주식회사 사이루스 | 에리스로포이에틴 유래 펩티드를 함유하는 세포증식 촉진용 조성물 |
| JP7560445B2 (ja) | 2018-09-10 | 2024-10-02 | コールド スプリング ハーバー ラボラトリー | 膵炎を処置するための方法 |
| JP2022529353A (ja) * | 2019-04-17 | 2022-06-21 | コンパス パスファインダー リミテッド | 神経認知障害、慢性疼痛を治療し、炎症を低減させる方法 |
| DE102019215585B4 (de) * | 2019-10-10 | 2022-02-17 | KCM Egészségügyi és Tudományos Korlátolt Felelösségü Társaság | Verfahren zur prävention von strahlenschäden in humanen drüsen |
| CA3170057A1 (en) | 2020-02-06 | 2021-09-10 | Austin Star Detonator Company | Integrated detonator sensors |
| DE102022112056A1 (de) | 2021-05-28 | 2022-12-01 | Shimano Inc. | Komponente für ein mit menschenkraft angetriebenes fahrzeug und elektrisches system für ein mit menschenkraft angetriebenes fahrzeug |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995004075A1 (en) * | 1993-07-28 | 1995-02-09 | Medvet Science Pty. Ltd. | Haemopoietic growth factor antagonists |
| IL124015A0 (en) * | 1998-04-08 | 1999-01-26 | Yeda Res & Dev | Pharmaceutical compositions comprising a protein |
| CN1318084C (zh) * | 2000-05-26 | 2007-05-30 | 奥索-麦克尼尔药品公司 | 神经保护肽 |
| KR20030074784A (ko) * | 2001-02-06 | 2003-09-19 | 메르크 파텐트 게엠베하 | 감소된 면역원성을 갖는 개질 에리트로포이에틴 (ｅｐｏ) |
| MXPA05001452A (es) * | 2002-08-09 | 2005-06-06 | Merck Patent Gmbh | Epitopes de celulas en eritropoyetina. |
| US7718363B2 (en) * | 2003-04-25 | 2010-05-18 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
| MX339613B (es) * | 2005-08-05 | 2016-06-02 | Araim Pharmaceuticals Inc | Peptidos protectores de tejido y sus usos. |
| JP2010510794A (ja) * | 2006-11-28 | 2010-04-08 | ハナル ファーマシューティカル カンパニー リミテッド | 修飾型エリスロポエチンポリペプチド及びこの治療用用途 |
| AU2008328754B2 (en) * | 2007-11-29 | 2015-04-16 | Molecular Health Gmbh | Novel tissue protective erythropoietin receptor (NEPOR) and methods of use |
| NZ601868A (en) * | 2008-01-22 | 2014-05-30 | Araim Pharmaceuticals Inc | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| WO2011022056A2 (en) * | 2009-08-18 | 2011-02-24 | Medical College Of Georgia Research Institute, Inc. | PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
-
2014
- 2014-07-16 CA CA2918223A patent/CA2918223A1/en not_active Abandoned
- 2014-07-16 JP JP2016527071A patent/JP6479789B2/ja not_active Expired - Fee Related
- 2014-07-16 KR KR1020167003632A patent/KR20160052537A/ko not_active Ceased
- 2014-07-16 EP EP14825674.6A patent/EP3021863A4/en not_active Withdrawn
- 2014-07-16 SG SG10201809099PA patent/SG10201809099PA/en unknown
- 2014-07-16 MX MX2016000448A patent/MX2016000448A/es unknown
- 2014-07-16 AU AU2014290116A patent/AU2014290116A1/en not_active Abandoned
- 2014-07-16 WO PCT/US2014/046839 patent/WO2015009820A2/en not_active Ceased
- 2014-07-16 HK HK16111663.5A patent/HK1223298A1/zh unknown
- 2014-07-16 US US14/905,754 patent/US20160168199A1/en not_active Abandoned
- 2014-07-16 SG SG11201600294QA patent/SG11201600294QA/en unknown
- 2014-07-16 CN CN201480049424.5A patent/CN105517561A/zh active Pending
-
2016
- 2016-01-11 IL IL243551A patent/IL243551A0/en unknown
- 2016-01-15 ZA ZA2016/00362A patent/ZA201600362B/en unknown
-
2019
- 2019-02-06 JP JP2019019259A patent/JP2019112406A/ja active Pending
-
2020
- 2020-01-17 AU AU2020200352A patent/AU2020200352A1/en not_active Abandoned
- 2020-05-19 US US16/878,318 patent/US20210107942A1/en not_active Abandoned
-
2021
- 2021-03-01 JP JP2021031378A patent/JP2021090447A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016531105A5 (enExample) | ||
| US11970480B2 (en) | Heterocyclic amides useful as protein modulators | |
| US11377440B2 (en) | Modulators of stimulator of interferon genes (STING) | |
| AU2018344902B2 (en) | Modulators of stimulator of interferon genes (STING) useful in treating HIV | |
| ES2387584T3 (es) | Derivados ésteres y amidas de indazolilo para el tratamiento de trastornos mediados por el receptor de glucocorticoides | |
| EA201992126A1 (ru) | Ингибиторы jak, содержащие 4-членный гетероциклический амид | |
| CA2731356C (en) | Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments | |
| JP2019529547A5 (enExample) | ||
| HUE032868T2 (en) | 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group | |
| EA201290515A1 (ru) | Аминопиримидины в качестве syk ингибиторов | |
| CA2884922C (en) | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | |
| ES2636864T3 (es) | Preparación de intermedios de pirimidina útiles para la fabricación de macitentán | |
| RS55012B1 (sr) | 5-[(3,3,3-trifluoro-2-hidroksi-1-arilpropil)amino]-1h-hinolin-2-on, procesi za njihovu proizvodnju i njihova upotreba kao anti-upalni agensi | |
| JP2019523633A5 (enExample) | ||
| EP3563851A1 (en) | Antitumor agent and bromodomain inhibitor | |
| US20220389032A1 (en) | Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting | |
| Kaur et al. | Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system | |
| Dejmek et al. | From norbornane-based nucleotide analogs locked in South conformation to novel inhibitors of feline herpes virus | |
| CN107207468A (zh) | 吡嗪甲酰胺化合物的制造方法及其合成中间体 | |
| CN115477639B (zh) | 一种以fgfr1为靶点的多取代嘧啶类化合物及其制备方法和用途 | |
| CA3147538A1 (en) | Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting | |
| WO2015113192A1 (zh) | 苯并内酰胺化合物及其合成方法和应用 | |
| RU2604068C1 (ru) | N-(2-аминопурин-6-ил)глицил-(s)-глутаминовая кислота, обладающая противотуберкулёзной активностью | |
| NZ594217A (en) | Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions | |
| WO2023126978A1 (en) | Process to prepare octopamine sulfate |